peptideInjectableResearch chemicalOnly studied in cell culture and animal models; no published human dosing protocol exists
Mechano Growth FactorBenefits, Dosage & Interactions
Also known as: MGF
Mechano Growth Factor (MGF) is a splice variant of Insulin-like Growth Factor-1 (IGF-1) that is naturally produced in response to mechanical stress, such as resistance exercise. It plays a crucial role in muscle regeneration and repair processes. Research on Mechano Growth Factor focuses on muscle and strength.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Preclinical — Animal and in-vitro studies only, no published human RCTs.
Evidence strengthPreclinical · 1/4
PreclinicalStrong human evidence
Animal and in-vitro studies only, no published human RCTs.
Plasma half-life
Not established
Default unit
mcg
References & evidence
Documents the Mechano Growth Factor entry is written from. Each number matches an inline marker above.
- [1]The role of mechano growth factor in chondrocytes and cartilage defects: a concise reviewLiu Y, Duan M, Zhang D, Xie J · Acta Biochimica et Biophysica Sinica · 2023 · Peer-reviewed · PMID 37171185
- [2]Mechano Growth Factor Accelerates ACL Repair and Improves Cell Mobility of Mechanically Injured Human ACL Fibroblasts by Targeting Rac1-PAK1/2 and RhoA-ROCK1 PathwaysSha Y, Zhang B, Chen L, Hong H, Chi Q · International Journal of Molecular Sciences · 2022 · Peer-reviewed · PMID 35457148
How to track Mechano Growth Factor doses
Mechano Growth Factor is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so Mechano Growth Factor is stored as a concentration rather than a guess. DoseRoutine converts that into mcg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mcg and the frequency. Cycled protocols get a start and end date so the history stays accurate when Mechano Growth Factor comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Mechano Growth Factor alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mcg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
What is Mechano Growth Factor studied for?
What is Mechano Growth Factor?
Mechano Growth Factor (MGF) is a splice variant of Insulin-like Growth Factor-1 (IGF-1) that is naturally produced in response to mechanical stress, such as resistance exercise. It plays a crucial role in muscle regeneration and repair processes. When muscle fibers are damaged, the IGF-1 gene is spliced in a way that produces MGF, which then acts locally to initiate muscle stem cell (satellite cell) activation and proliferation. This activation is essential for the repair of damaged muscle tissue and the growth of new muscle fibers, contributing to muscle hypertrophy.
Unlike systemically circulating IGF-1, MGF is thought to exert its effects primarily within the muscle tissue where it is produced, making it a localized mediator of muscle adaptation. Research into MGF explores its potential applications in sports science, regenerative medicine, and age-related muscle wasting conditions (sarcopenia). As a peptide, MGF is typically administered via injection, and its half-life in the body is relatively short. Its classification as a peptide means it's a chain of amino acids, smaller than a protein, and it interacts with specific receptors to elicit its biological effects.
What does the research say about Mechano Growth Factor?
Tap a section to expand.
Mechano Growth Factor (MGF) is a potent autocrine/paracrine growth factor primarily involved in muscle repair and regeneration. Its mechanism of action begins with mechanical stress on muscle tissue, typically from resistance exercise. This stress triggers a 'splicing' event of the Insulin-like Growth Factor-1 (IGF-1) gene, leading to the production of MGF, specifically the ECa peptide fragment. MGF is distinct from the liver-derived, systemic IGF-1.
Upon its release in the damaged muscle, MGF binds to specific IGF-1 receptors (IGF-1R) on muscle cells and, more critically, on quiescent muscle stem cells, known as satellite cells. This binding initiates a cascade of intracellular signaling pathways, notably the MAPK/ERK pathway and the PI3K/Akt pathway. Activation of these pathways is fundamental to:
1. **Satellite Cell Activation and Proliferation:** MGF is a powerful activator of quiescent satellite cells, stimulating them to leave their dormant state and begin dividing. This proliferation increases the pool of cells available for muscle repair.
2. **Differentiation of Satellite Cells:** While MGF primarily promotes proliferation, it also influences the differentiation process, ensuring that these new cells mature into functioning muscle fibers or fuse with existing damaged fibers to repair and enlarge them.
3. **Protein Synthesis:** MGF contributes to increased protein synthesis within muscle cells, which is vital for muscle growth and repair.
4. **Anti-Apoptotic Effects:** Research suggests MGF may have protective effects against muscle cell apoptosis (programmed cell death), further supporting muscle integrity during stress and recovery.
Crucially, MGF acts locally within the muscle tissue, targeting the site of injury or stress, which differentiates its action from that of systemic IGF-1. This localized action is thought to promote efficient and targeted muscle repair and adaptation to mechanical loads. (PubChem)
Mechano Growth Factor (MGF) is primarily studied for its role in muscle repair and growth. The potential benefits, largely derived from animal studies and *in vitro* research, include:
* **Enhanced Muscle Regeneration:** MGF is known to activate satellite cells, which are crucial for repairing damaged muscle fibers and forming new ones. This process can lead to faster and more efficient recovery from muscle injury and intense exercise. (PubChem)
* **Promotion of Muscle Hypertrophy:** By stimulating satellite cell proliferation and differentiation, MGF contributes to an increase in muscle fiber size and number, potentially leading to greater muscle mass. (PubChem)
* **Improved Muscle Repair After Injury:** Due to its localized action and ability to stimulate regenerative processes, MGF may support more effective healing of muscle tears and strains. This has implications for both athletes and individuals experiencing muscle injuries. (DrugBank)
* **Potential in Combating Sarcopenia:** As a factor that promotes muscle growth and regeneration, MGF is being investigated for its potential to mitigate age-related muscle loss (sarcopenia), which is a common condition affecting older adults and leading to decreased strength and mobility. (DrugBank)
* **Localized Action:** Unlike systemic growth factors, MGF's localized production and action mean that its effects are concentrated on the muscle tissue experiencing stress or damage, potentially leading to more targeted benefits. (PubChem)
It's important to note that while the mechanisms and potential benefits are biologically plausible and supported by preclinical research, human clinical trials demonstrating these benefits conclusively are limited and ongoing. The effects observed in animal models do not always directly translate to humans.
The evidence for Mechano Growth Factor (MGF)'s effects largely stems from *in vitro* studies and animal models, with human research being more nascent or focused on detecting its presence rather than therapeutic efficacy.
* **Animal Studies:** Numerous studies in rodents have demonstrated MGF's ability to promote muscle regeneration and hypertrophy. For instance, research has shown that MGF expression is significantly upregulated in response to mechanical overload or injury in rat and mouse muscles, leading to increased satellite cell activity, muscle fiber repair, and growth. These studies frequently involve direct injection of MGF into muscle tissue or its overexpression via gene transfer. (DrugBank, PubChem)
* **Cellular Studies (*in vitro*):** *In vitro* experiments using cultured muscle cells (myoblasts) have shown that MGF directly stimulates the proliferation of these cells, prevents apoptosis, and promotes their differentiation into mature muscle fibers. This provides strong mechanistic support for its role in muscle repair and growth at the cellular level. (PubChem)
* **Human Detection and Correlation:** In humans, MGF mRNA (the genetic blueprint for MGF) has been found to increase in muscle tissue following resistance exercise, suggesting a physiological role in exercise-induced muscle adaptation and repair. However, robust clinical trials investigating the direct therapeutic benefit of exogenous MGF administration in humans for muscle growth or repair are limited. The World Anti-Doping Agency (WADA) has banned MGF due to its potential performance-enhancing effects, indicating a recognition of its biological activity, even if comprehensive human efficacy data from controlled trials are scarce. (DrugBank)
Overall, while the biological mechanisms and preclinical evidence strongly suggest a role for MGF in muscle repair and growth, direct clinical evidence in humans for its use as a therapeutic agent is still developing. Researchers continue to explore its potential in conditions like sarcopenia and muscle wasting, but its status as a research compound rather than an approved drug underscores the need for further human trials.
As Mechano Growth Factor (MGF) is primarily a research peptide and not an approved therapeutic drug, comprehensive data on its side effects in humans are limited from controlled clinical trials. However, based on its biological nature as a growth factor and anecdotal reports from its use in research settings or by individuals outside of clinical oversight, potential side effects might include:
* **Injection Site Reactions:** As an injectable peptide, MGF can cause localized pain, redness, swelling, or irritation at the injection site. This is a common side effect of many injectable compounds.
* **Hypoglycemia (Low Blood Sugar):** While MGF is distinct from systemic IGF-1, IGF-1 itself can influence glucose metabolism. There is theoretical concern that MGF, particularly if administered in high doses or systemically, could potentially lead to alterations in blood sugar levels, though this is less established than with exogenous IGF-1.
* **Potential for Abnormal Tissue Growth:** As a growth factor, MGF promotes cell proliferation. There is a theoretical concern regarding its long-term effects on the growth of non-muscle tissues, or its potential to exacerbate the growth of existing undiagnosed tumors or cancerous cells, although direct evidence for this specific to MGF in humans is lacking.
* **Immunogenicity:** As with any exogenous peptide, there is a possibility for the body to develop an immune response, leading to antibody formation, which could neutralize the peptide's effects or cause allergic reactions.
* **Cardiac Effects:** Some growth factors can influence cardiac tissue. While not directly established for MGF, the broad category of growth factors can sometimes induce concerns about cardiovascular effects, especially with supraphysiological doses.
It is crucial to understand that user-reported experiences or observations in non-clinical settings are not equivalent to data from rigorous clinical trials. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Mechano Growth Factor (MGF) is a research peptide and not approved for human therapeutic use by regulatory bodies like the FDA or EMA. Therefore, general warnings when considering its use include:
* **Legality and Regulatory Status:** MGF is banned by the World Anti-Doping Agency (WADA) due to its potential for performance enhancement and is classified as a controlled substance in some regions. Its legal status for personal use varies.
* **Lack of Clinical Data:** There is a significant lack of large-scale, placebo-controlled human clinical trials establishing the safety and efficacy of MGF. Most information comes from preclinical (animal and *in vitro*) studies or anecdotal reports, which are not sufficient to determine safe dosing, long-term effects, or drug interactions.
* **Unknown Long-Term Effects:** Due to the absence of long-term human studies, the potential consequences of prolonged MGF administration on various bodily systems, including endocrine health, cardiovascular health, and cancer risk, are unknown.
* **Purity and Quality Concerns:** When sourcing MGF from unregulated channels, there is a high risk of obtaining products that are impure, mislabeled, contain contaminants, or have incorrect dosages. These quality issues can lead to unpredictable effects or pose significant health risks.
* **Potential for Cancer Risk:** As a growth factor, MGF promotes cell proliferation. While direct evidence for MGF causing cancer in humans is lacking, the theoretical risk that it could accelerate the growth of existing undiagnosed cancers or promote oncogenesis cannot be entirely dismissed without extensive research.
* **Hypoglycemia Risk:** Although MGF's direct impact on systemic glucose regulation is less understood than that of IGF-1, caution is advised for individuals with diabetes or those prone to hypoglycemia, as growth factors can sometimes influence glucose metabolism.
* **Administration Risks:** As an injectable compound, administration carries risks such as infection, nerve damage, or localized tissue damage if not performed with sterile technique by a trained professional.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Given the limited human clinical data for Mechano Growth Factor (MGF), specific contraindications are not formally established by regulatory bodies. However, based on its mechanism of action as a growth factor and general principles of pharmacology, potential contraindications would logically include:
* **Active Cancer or History of Cancer:** MGF promotes cell proliferation. Therefore, individuals with an active cancer diagnosis or a history of cancer should avoid MGF due to the theoretical risk of accelerating tumor growth or recurrence. This is a significant concern for any compound that stimulates cell division.
* **Pregnancy and Breastfeeding:** There is no safety data on MGF use during pregnancy or lactation. As with most unapproved compounds, it should be strictly avoided by pregnant or breastfeeding individuals due to potential risks to the developing fetus or infant.
* **Children and Adolescents:** MGF is not recommended for individuals under the age of 18, as its effects on growing bodies, bone development, and hormonal systems are unknown and could be detrimental.
* **Pre-existing Cardiovascular Conditions:** While not definitively linked to MGF, some growth factors can have effects on the cardiovascular system. Individuals with established heart conditions should exercise extreme caution or avoid MGF.
* **Diabetes or Glucose Dysregulation:** Although MGF's direct impact on blood sugar is less clear than that of IGF-1, caution might be warranted for individuals with diabetes or those experiencing glucose control issues, as growth factors can sometimes influence metabolic pathways.
* **Hypersensitivity or Allergy:** Any individual with a known hypersensitivity or allergic reaction to peptides or any components within MGF formulations should avoid its use.
* **Uncontrolled Medical Conditions:** Individuals with any severe or uncontrolled underlying medical conditions should avoid MGF due to the unpredictable nature of its interaction with complex physiological systems.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
As Mechano Growth Factor (MGF) is a research peptide with limited human clinical data, there are no formally established 'do not mix' recommendations based on rigorous clinical trials. However, theoretical considerations and general principles concerning growth factors suggest caution when combining MGF with certain substances:
* **Other Growth Factors or Anabolic Agents:** Combining MGF with other growth factors (e.g., exogenous IGF-1, growth hormone) or anabolic steroids could potentially amplify the effects on cell proliferation and protein synthesis. This could lead to an increased risk of side effects, including disproportionate tissue growth, metabolic disturbances, or unknown long-term health consequences due to synergistic or additive effects that have not been studied. (DrugBank, PubChem)
* **Insulin:** Both MGF (indirectly) and insulin affect glucose metabolism. Combining MGF with insulin, especially without medical supervision, could potentially complicate blood sugar regulation and increase the risk of hypoglycemia. (PubChem)
* **Cancer Therapies:** Given the theoretical concern that MGF could promote cell growth, combining it with therapies designed to inhibit cell growth (e.g., chemotherapy, radiation therapy, targeted cancer drugs) would be highly contraindicated, as it could counteract the intended effects of such treatments.
* **Immune-modulating Drugs:** If MGF were to induce an immune response, combining it with immune-modulating drugs could theoretically alter this response, though this is speculative.
Since MGF is not an approved therapeutic and its interactions have not been systematically studied, the safest approach is to assume potential interactions with any other medications, supplements, or hormones. Therefore, exercise extreme caution or avoid combining MGF with other active compounds, especially those that influence cell growth, metabolism, or the endocrine system.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Mechano Growth Factor (MGF) has a relatively short half-life of approximately 1 hour. Its typical timing of administration, when used in research or experimental settings, often aims to coincide with periods of muscle repair and growth, primarily post-exercise.
* **Post-Workout:** A common approach is to administer MGF shortly after resistance training. The rationale is to leverage the body's natural window of increased MGF production in response to mechanical stress and potentially enhance the regenerative processes already initiated by exercise. This strategic timing aims to maximize the local effects of MGF when muscle tissue is most receptive to repair and growth signals. Its short half-life suggests that more frequent administration (potentially daily or multiple times per day, if deemed necessary based on specific research protocols) might be considered to maintain elevated levels, though this would need to balance potential benefits against increased side effect risks.
* **Anytime:** While post-workout is biologically logical, if the goal is generalized muscle repair or recovery from injury, administration at other times could also be considered, possibly daily regardless of workout timing, to support ongoing regenerative processes. However, the exact 'best' timing and frequency are not definitively established in human clinical trials.
For any individual considering MGF, the dose and timing must be user-directed and determined by a licensed clinician due to the peptide's status as a research compound and the lack of standardized protocols.
What interacts with Mechano Growth Factor?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Mechano Growth Factor
Mechano Growth Factor is a research peptide. It is also known as MGF. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.
Mechano Growth Factor is commonly discussed in the context of supporting muscle. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Mechano Growth Factor, it is typically administered by injection and it is typically taken null. Always follow the specific dose your clinician or the product label prescribes.
Mechano Growth Factor carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
Interaction risk for Mechano Growth Factor comes from the rest of the stack: other peptides, prescription medicines, hormone therapy and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Mechano Growth Factor with no sign-up.
There is no single answer for Mechano Growth Factor plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Mechano Growth Factor with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Mechano Growth Factor varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Mechano Growth Factor depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like Mechano Growth Factor the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Mechano Growth Factor?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Growth factors and muscle ageing(opens PubMed in a new tab)Exp Gerontol · 2004 · PMID 15501012 · https://pubmed.ncbi.nlm.nih.gov/15501012/
- 2.The role of mechano growth factor in chondrocytes and cartilage defects: a concise review(opens PubMed in a new tab)Acta Biochim Biophys Sin (Shanghai) · 2023 · PMID 37171185 · https://pubmed.ncbi.nlm.nih.gov/37171185/
- 3.Ageing and local growth factors in muscle(opens PubMed in a new tab)Scand J Med Sci Sports · 2003 · PMID 12535315 · https://pubmed.ncbi.nlm.nih.gov/12535315/
- 4.Effects of activity on growth factor expression(opens PubMed in a new tab)Int J Sport Nutr Exerc Metab · 2001 · PMID 11915923 · https://pubmed.ncbi.nlm.nih.gov/11915923/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- WADA Prohibited List(opens in a new tab)World Anti-Doping Agency · wada-ama.org/en/prohibited-list
Verify at
Publisher search links for Mechano Growth Factor. These are places to check the information — they are not citations, so they are not numbered.
- PubChem(publisher search, opens in a new tab)National Center for Biotechnology Information · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Mechano Growth Factor?
Plain-text summary, safe to quote verbatim:
Mechano Growth Factor (MGF) is a splice variant of Insulin-like Growth Factor-1 (IGF-1) that is naturally produced in response to mechanical stress, such as resistance exercise. It plays a crucial role in muscle regeneration and repair processes. Research on Mechano Growth Factor focuses on muscle and strength.
Source: DoseRoutine — https://doseroutine.com/library/mechano-growth-factor
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Mechano Growth Factor — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/mechano-growth-factor
What compounds are similar to Mechano Growth Factor?
Others in the peptide category or studied for the same goals.
Which goals is Mechano Growth Factor used for?
Other compounds studied for the same benefits as Mechano Growth Factor.
Continue exploring
See every compound DoseRoutine catalogs for these goals.